Skip to content

Effects of Sodium Bicarbonate on Endurance Performance

Effects of Sodium Bicarbonate Supplementation on Endurance Performance and Physiological Responses During Simulated Cycling Competition

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07171047
Acronym
SBEP
Enrollment
19
Registered
2025-09-12
Start date
2025-09-15
Completion date
2025-12-12
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Athlete, Healthy, Performance, Well-trained Athletes

Keywords

Bicarbonate, Endurance training, Cycling, Time trial

Brief summary

This study is investigating whether taking sodium bicarbonate, a common supplement used by endurance athletes, can improve cycling performance during prolonged exercise and in a time trial. Sodium bicarbonate may help reduce muscle acidity, which could delay fatigue and improve performance. The goal of this study is to determine if this supplement can help athletes perform better during long, intense efforts like those seen in real competitions. Participants in this study are well-trained cyclists who will complete two exercise trials in a laboratory setting. Each trial involves three hours of moderate cycling followed by a 20-30-minute time trial at maximum effort. Before each trial, participants will take either sodium bicarbonate or a placebo. The study will measure performance outcomes, such as time trial results, as well as physiological responses, including heart rate, oxygen use, and muscle fatigue. Researchers hope to better understand how sodium bicarbonate can help endurance athletes and provide guidelines for its use in competitive sports.

Interventions

DIETARY_SUPPLEMENTPlacebo then Verum

Intake of 0.3 g/kg bodyweight of maltodextrin with hydrogel as placebo and 0.3 g/kg bodyweight of sodium bicarbonate with hydrogel as Verum

DIETARY_SUPPLEMENTVerum then Placebo

Intake of 0.3 g/kg bodyweight of maltodextrin with hydrogel as placebo and 0.3 g/kg bodyweight of sodium bicarbonate with hydrogel as Verum

Sponsors

University of Salzburg
Lead SponsorOTHER
Red Bull Athlete Performance Center
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Intervention model description

Double blinded two-intervention crossover study

Eligibility

Sex/Gender
ALL
Age
16 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* age 16-50 years * well-trained cyclists * Proof of physical fitness (e.g. sports medical examination required) for measurements with higher intensities (e.g. endurance tests, competition simulation) * \>10h endurance training per week

Exclusion criteria

* Systemic disease or other known pathology in the organs: heart, lungs, kidney, stomach, spleen, liver, gall bladder, and intestines. * Evidence of pulmonary disease: forced expiratory volume in one second/forced expiratory volume \< 70% with/without symptoms (cough, sputum) or other evidence of pulmonologic disease. Diabetes II.

Design outcomes

Primary

MeasureTime frameDescription
Endurance performance20-30 minutes, immediately after completion of the time trial for each condition (Placebo and Verum), assessed on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).Difference in time trial performance (average power in watts) between placebo and verum condition

Secondary

MeasureTime frameDescription
Difference in questionnaire score - gastrointestinal symptoms6.5 hours (rest, breakfast, every 30min during 3-hour low-intensity, after TT) for each condition (Placebo and Verum), on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).Difference in questionnaire score gastrointestinal symptoms between placebo and verum condition (0-10, higher score indicates more severe symptoms).
Difference in questionnaire score - Energy & Confidence3 hours (every 30min during 3-hour low-intensity) for each condition (Placebo and Verum), assessed on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).Difference in questionnaire score energy and confidence in time trial performance between placebo and verum condition (0-10, higher score indicates more Energy or Confidence in time trial performance).
Difference in questionnaire score - rate of perceived exertion3.5 hours (every 30min during 3-hour low-intensity, after TT) for each condition (Placebo and Verum), assessed on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).Difference in questionnaire score overall and legs only perceived exertion between placebo and verum condition (0-10, higher score indicates a higher degree of perceived exertion).
Difference in blood count6.5 hours (rest, every 30min during 3-hour low-intensity, after TT) for each condition (Placebo and Verum), assessed on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).Difference in capillary blood count between placebo and verum condition
Difference in pH & HCO3 kinetics6.5 hours (rest, breakfast, every 30min during 3-hour low-intensity, after TT) for each condition (Placebo and Verum), on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).Difference in pH \& HCO3 kinetics between placebo, verum and resting verum condition
Difference in heart rate3.5 hours, assessed continuously (every second) during 3 hour low-intensity and TT for each condition (Placebo and Verum), on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).Difference in heart rate (bpm) between placebo and verum condition
Difference in oxygen uptake3 hours, assessed for 5 min every 30 min during 3 hour low-intensity for each condition (Placebo and Verum), on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).Difference in oxygen uptake (ml/kg/min) between placebo and verum condition
Difference in blood lactate concentration3.5 hours, assessed every 30 min during 3 hour low-intensity and after TT for each condition (Placebo and Verum), on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).Difference in blood lactate concentration (mmol/L) between placebo and verum condition.
Difference in substrate utilization3 hours, assessed for 5 min every 30 min during 3 hour low-intensity for each condition (Placebo and Verum), on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).Difference in substrate utilization between placebo and verum condition.
Difference in ventilation3 hours, assessed for 5 min every 30 min during 3 hour low-intensity for each condition (Placebo and Verum), on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).Difference in ventilation (L/min) between placebo and verum condition
Difference in core body temperature3.5 hours, assessed continuously during 3 hour low-intensity and TT for each condition (Placebo and Verum), on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).Difference in core body temperature (°) between placebo and verum condition.
Difference in muscle oxygenation3.5 hours, assessed continuously during 3 hour low-intensity and TT for each condition (Placebo and Verum), on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).Difference in muscle oxygenation (SmO2) of the vastus lateralis between placebo and verum condition.
Difference in glucose level24 hours, assessed continuously for each condition (Placebo and Verum), on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).Difference in glucose level (mg/dl) between placebo and verum condition.
Difference in sodium content3.5 hours, assessed during 3 hour low-intensity and TT for each condition (Placebo and Verum), on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).Difference in sodium content (mg/hr) between placebo and verum condition
Difference in sweat rate3.5 hours, assessed during 3 hour low-intensity and TT for each condition (Placebo and Verum), on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).Difference in sweat rate (L/hr) between placebo and verum condition.
Difference in next morning weight24 hours, assessed in the morning for each condition (Placebo and Verum) and the following day, on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).Difference in weight (kg) measured in the morning of the test day and the following day (before breakfast after urination and defecation)

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026